Bevasiranib sodium is a siRNA designed to silence the genes that produce vascular endothelial growth factor (VEGF). It is widely accepted that vascular endothelial growth factor (VEGF) is a key component in the pathogenesis of choroidal neo-vascularization (CNV), which is a precursor to wet age-related macular degeneration (wet AMD).
Molecular Weight:
13345.2 (free acid)
Purity:
97.68
CAS Number:
[849758-52-7]
Formula:
C401H463N153Na40O290P40
Target:
Small Interfering RNA (siRNA),VEGFR
Application Notes:
MCE Product type: Oligonucleotides
* VAT and and shipping costs not included. Errors and price changes excepted
